RDE233 -Staphylococcus aureus in cases of bovine mastitis and in humans

VMDcontractContracts FinderRef CF-0178300D8d000003VQwdEAGcomplete
View buyer

Estimated value

£39k

Awarded value

£39k

Awarded 30 Jan 2023

Suppliers

1

Lots

1

1 awarded

Published

09 Nov 2023

Deadline 30 Jan 2023

Description

The VMD seeks to commission research into this area, the objectives of which would be to: • Determine the rates of and changes in antimicrobial resistance in S. aureus isolates from bovine mastitis over the period 2007-2022, including sensitivity testing of isolates not previously done. • Initially genotype additional bovine mastitis isolates of S. aureus by spa typing, in particular those before 2015 and after 2018. • Investigate the sharing of spa types circulating within bovine and human populations. • Select bovine mastitis and human S. aureus strains for whole genome sequencing, based on spa type, to obtain a better resolution of the population structure and determine the presence of AMR genes and host adaptation and virulence factors. Where possible, this may include following individual farms over the period of study. This contract was awarded by VMD.

Scope

Reference
CF-0178300D8d000003VQwdEAG
Total value
£39,463 excluding VAT
Commercial tool
Standalone contract
Contract dates
01 Feb 2023 to 30 Mar 2023
CPV classifications
73200000

Submission & procedure

Submission deadline
30 Jan 2023, 12:00 pm

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£39k

Award date

30 Jan 2023

Contract start

01 Feb 2023

Contract end

30 Mar 2023

Awarded to